Herpes Vaccine in Clinical Trials; Gene-Eden-VIR Remains Effective, Antiviral Natural
Designed to stimulate T cell and B cell immune responses, GEN-003 is an
investigational vaccine that works to potentially reduce the frequency and
severity of Herpes Simplex Virus type 2 (HSV-2) infection.
The Center for the Biology of Chronic
Disease (CBCD), learned recently that Genocea Biosciences has commenced a
phase I/II a clinical study with its lead candidate, GEN-003. Designed to
stimulate T cell and B cell immune responses, GEN-003 is an investigational
vaccine that works to potentially reduce the frequency and severity of
clinical outbreaks associated with moderate-to-severe Herpes Simplex Virus
type 2 (HSV-2) infection.
The experimental vaccine consists of two
proteins, ICP4 and gD2, as well as Matrix M, a proprietary adjuvant from
Preclinical studies of GEN-003 have
demonstrated the ability of the candidate vaccine to elicit strong and lasting
B and T cell immune responses, and have also shown a significant impact on the
severity and duration of genital herpes symptoms.
Mike Evans, from the CBCD said, "It will be
very interesting to see how Genocea's clinical trials of Gen-003 turn out. Any
vaccine that drastically reduces genital herpes outbreaks or eliminates them
entirely will be a welcome breakthrough."
Until such a breakthrough is approved,
however, the CBCD would like to remind the public that current treatments for
genital herpes outbreaks can be inconvenient. This is due to their high cost
as well as potential side effects.
Usually, therapeutic options are limited to
daily antiviral medications or suppressive therapy. However, there are all
natural herpes remedies on the market today that are remarkably effective in
fighting the latent herpes virus.
When someone is infected with the herpes
virus, after an initial period of activity where there can be up to 5 major
outbreaks in a year, Herpes establishes what scientists call a latent
infection. When a virus is latent, it acts as if it is asleep. It is dormant.
The moment your immune system is weakened however, the Herpes virus can "wake
up" and become active again.
The best defense against a latent herpes
infection is a healthy immune system.
That's why the CBCD would like to point out
a Herpes remedy that boosts the immune system and helps target the latent
(dormant) HSV virus.
"The key to your health is to reduce the
level of the chronic viruses in your body to harmless levels." - Dr. Hanan
The name of that herpes remedy is
Gene-Eden-VIR. This scientifically designed, all-natural product helps the
human body maintain low numbers of the latent (dormant) herpes virus.
By helping the body's immune system target
the latent herpes virus, people also lower their risk of developing fever
blisters, cold sores, or genital herpes symptoms. This is just one reason the
CBCD believes Gene-Eden-VIR is an important product.
Gene-Eden-VIR is highly efficient in
fighting the latent herpes virus; each ingredient was chosen through a
scientific approach. Scientists scanned thousands of scientific and medical
papers published in various medical and scientific journals around the world
to identify the safest, most effective natural ingredients that target the
latent forms of both HSV-1 and HSV-2.
Gene-Eden-VIR is quite safe. It has been on
the market for over three years, and in that time, no side effects were
reported. Each capsule contains a patented formula of five all natural
ingredients including selenium, camellia sinesis extract, quercetin,
cinnamomum extract, and licorice extract. In addition, each bottle is GMP
You can buy Gene-Eden-VIR online through
the Gene-Eden website at buy-gene-eden.com.
Each bottle of Gene-Eden-VIR (a one month's
supply) costs just $37.99.
To learn more about Gene-Eden-VIR, the only
product on the market today that helps the body fight the latent herpes virus
and that is scientifically backed by published material, visit